(MedPage Today) — The devastating consequences of mucopolysaccharidosis II (MPS II), also called Hunter syndrome, may soon become preventable if early results with an investigational enzyme replacement therapy prove out in randomized trials….
Source link : https://www.medpagetoday.com/neurology/generalneurology/119228
Author :
Publish date : 2025-12-31 13:44:00
Copyright for syndicated content belongs to the linked Source.
